About Robert N. Cooney, MD
Specialties & classifications: Bariatric surgery (directory-reported) · Surgery · Surgery, Surgical Critical Care
Robert N. Cooney, MD has a listed practice in Syracuse, NY. Contact the practice to confirm appointment availability, current services and insurance coverage.
Questions and Answers
Where is the listed practice?
750 E Adams St, Syracuse, NY, 13210. This is the registry-reported practice address; confirm the appointment location with the office. Source
Which insurance plans are listed?
A verified plan list is not available in this record. Confirm coverage directly with the practice and your insurer. Source
How can I check professional registration?
The NPI Registry record is 1639136237. NPI registration is separate from state licensure and board certification. Source
Education and Training
- Medical school · 1985
University Of Vermont College Of Medicine
MD
Source ↗ - Education and training
Image: UMass Chan Medical School
Source ↗ - Education and training
UMass Chan Medical School Residency, Surgery, 1988 - 1991
Source ↗ - Education and training
Image: University of California (San Diego) Medical Center
Source ↗ - Education and training
University of California (San Diego) Medical Center Residency, Surgery, 1987 - 1988
Source ↗ - Education and training
UMass Chan Medical School Residency, Surgery, 1986 - 1987
Source ↗ - Education and training
Image: St Elizabeth's Medical Center/Lemuel Shattuck Hospital
Source ↗ - Education and training
St Elizabeth's Medical Center/Lemuel Shattuck Hospital Internship, Transitional Year, 1985 - 1986
Source ↗ - Education and training
Image: University of Vermont College of Medicine
Source ↗ - Education and training
University of Vermont College of Medicine Class of 1985
Source ↗
Source-reported information; confirm current details directly.
Reported credentials
Source-reported information; confirm current details directly.
Reported affiliations
- UNIVERSITY SURGICAL ASSOCIATES LLP Source ↗
Source-reported information; confirm current details directly.
Selected publications
- Effects of sitagliptin combined with GTS-21 on improving glycemic control and diabetic nephropathy by anti-apoptosis in Lepr<sup>db/db</sup> mice. · 2026 Source ↗
- Mesenchymal stem cell - derived extracellular vesicles modulate immune function in sepsis. · 2026 Source ↗
- Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation. · 2026 Source ↗
- Telodendrimer nanotrap for selective cytokine removal from sepsis patient plasma. · 2026 Source ↗
- GTS-21 Alleviates Acute Lung Injury by Enhancing GLP-1 Secretion and Regulating Alveolar Surfactant Proteins via α7nAChR Activation. · 2026 Source ↗
- Harnessing Telodendrimer Nanotraps in Nanogels for Systemic Immune Modulation in Sepsis Treatment. · 2025 Source ↗
- GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4. · 2025 Source ↗
- Sparstolonin B nano-formulation attenuates LPS-induced lung injury. · 2025 Source ↗
- Pathogenesis and therapeutic effect of sitagliptin in experimental diabetic model of COVID-19. · 2025 Source ↗
- INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS-DERIVED EXTRACELLULAR VESICLES ATTENUATE LPS-INDUCED LUNG INJURY AND ENDOTOXEMIA IN MICE. · 2024 Source ↗
- Lineage-Specific Mesenchymal Stromal Cells Derived from Human iPSCs Showed Distinct Patterns in Transcriptomic Profile and Extracellular Vesicle Production. · 2024 Source ↗
- LIRAGLUTIDE ALLEVIATES ACUTE LUNG INJURY AND MORTALITY IN PNEUMONIA-INDUCED SEPSIS THROUGH REGULATING SURFACTANT PROTEIN EXPRESSION AND SECRETION. · 2024 Source ↗
- Impact of intestinal microenvironments in obesity and bariatric surgery on shaping macrophages. · 2023 Source ↗
- Galantamine improves glycemic control and diabetic nephropathy in Lepr<sup>db/db</sup> mice. · 2023 Source ↗
- GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Lepr<sup>db/db</sup> mice. · 2022 Source ↗
- Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat. · 2022 Source ↗
- Functionalized core-shell nanogel scavenger for immune modulation therapy in sepsis. · 2022 Source ↗
- The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice. · 2022 Source ↗
- Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation. · 2022 Source ↗
- Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation. · 2020 Source ↗
- A nanotrap improves survival in severe sepsis by attenuating hyperinflammation. · 2020 Source ↗
- A systematic review and meta-analysis of predictors of recurrence in patients with Solid Pseudopapillary Tumors of the Pancreas. · 2020 Source ↗
- Osteoclast-like giant cell tumor of the pancreas-an unusual presentation in a patient with large mantle cell lymphoma. · 2018 Source ↗
- Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling. · 2018 Source ↗
- Enteral administration of bacteria fermented formula in newborn piglets: A high fidelity model for necrotizing enterocolitis (NEC). · 2018 Source ↗
- α7 Nicotinic Acetylcholine Receptor Regulates the Function and Viability of L Cells. · 2018 Source ↗
- Surfactant Proteins-A and -D Attenuate LPS-Induced Apoptosis in Primary Intestinal Epithelial Cells (IECs). · 2018 Source ↗
- Protective effects of glutathione on oxidative injury induced by hydrogen peroxide in intestinal epithelial cells. · 2018 Source ↗
- Impact of ASA score misclassification on NSQIP predicted mortality: a retrospective analysis. · 2017 Source ↗
- Spontaneous splenic rupture due to marginal zone lymphoma. · 2017 Source ↗
- Endovascular stent graft repair of an abdominal gunshot with liver and aortic injuries. · 2017 Source ↗
- L-arginine attenuates Interleukin-1β (IL-1β) induced Nuclear Factor Kappa-Beta (NF-κB) activation in Caco-2 cells. · 2017 Source ↗
- Using the ACGME Milestones for Resident Self-Evaluation and Faculty Engagement. · 2016 Source ↗
- Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategy. · 2016 Source ↗
- Trauma transfers to a rural level 1 center: a retrospective cohort study. · 2016 Source ↗
- Innate Immune Molecule Surfactant Protein D Attenuates Sepsis-induced Acute Pancreatic Injury through Modulating Apoptosis and NF-κB-mediated Inflammation. · 2015 Source ↗
- Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia. · 2016 Source ↗
- Roux-en-Y Gastric Bypass Alters Brain Activity in Regions that Underlie Reward and Taste Perception. · 2015 Source ↗
- Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli. · 2016 Source ↗
- Time-related increase in urinary testosterone levels and stable semen analysis parameters after bariatric surgery in men. · 2015 Source ↗
- Determining energy needs in critically ill patients: equations or indirect calorimeters. · 2012 Source ↗
Source-reported information; confirm current details directly.
Professional identifier
NPI: 1639136237
Ratings & reviews
Write a review